Morpholino

MO2-camk1da

ID
ZDB-MRPHLNO-160621-10
Name
MO2-camk1da
Previous Names
  • Exon 2 (1)
Target
Sequence
5' - GCACCCCTTTAAAAGAGAGAGGAGA - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-camk1da
Expressed Gene Anatomy Figures
tp53 Fig. S7 from O'Hare et al., 2016
Phenotype
Phenotype resulting from MO2-camk1da
Phenotype Fish Figures
endocrine pancreas EGFP expression decreased distribution, abnormal nl1Tg + MO2-camk1da Fig. S10 from O'Hare et al., 2016
endocrine pancreas decreased size, abnormal nl1Tg + MO2-camk1da Fig. S10 from O'Hare et al., 2016
endocrine pancreas development disrupted, abnormal nl1Tg + MO2-camk1da Fig. S10 from O'Hare et al., 2016
enteroendocrine cell differentiation disrupted, abnormal nl1Tg + MO2-camk1da Fig. S10 from O'Hare et al., 2016
pancreatic B cell decreased area, abnormal jh1Tg; jh2Tg + MO2-camk1da Fig. 1 from O'Hare et al., 2016
whole organism tp53 expression increased amount, abnormal jh1Tg; jh2Tg + MO2-camk1da Fig. S7 from O'Hare et al., 2016
Phenotype of all Fish created by or utilizing MO2-camk1da
Phenotype Fish Conditions Figures
endocrine pancreas EGFP expression decreased distribution, abnormal nl1Tg + MO2-camk1da standard conditions Fig. S10 from O'Hare et al., 2016
endocrine pancreas development disrupted, abnormal nl1Tg + MO2-camk1da standard conditions Fig. S10 from O'Hare et al., 2016
endocrine pancreas decreased size, abnormal nl1Tg + MO2-camk1da standard conditions Fig. S10 from O'Hare et al., 2016
enteroendocrine cell differentiation disrupted, abnormal nl1Tg + MO2-camk1da standard conditions Fig. S10 from O'Hare et al., 2016
whole organism tp53 expression increased amount, abnormal jh1Tg; jh2Tg + MO2-camk1da standard conditions Fig. S7 from O'Hare et al., 2016
pancreatic B cell increased amount, abnormal jh1Tg; jh2Tg + MO2-camk1da chemical treatment by environment: glucose Fig. 4 from O'Hare et al., 2016
pancreatic B cell decreased area, abnormal jh1Tg; jh2Tg + MO2-camk1da standard conditions Fig. 1 from O'Hare et al., 2016
pancreatic B cell regeneration decreased rate, abnormal jh4Tg + MO2-camk1da chemical ablation: pancreatic B cell, chemical treatment by environment: metronidazole Fig. 5 from O'Hare et al., 2016
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.